Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank57
3Y CAGR-5.2%
5Y CAGR+18.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-5.2%/yr
vs +46.1%/yr prior
5Y CAGR
+18.8%/yr
Recent deceleration
Acceleration
-51.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $157.39M | -29.0% |
| 2024 | $221.63M | +17.2% |
| 2023 | $189.15M | +2.5% |
| 2022 | $184.50M | +58.5% |
| 2021 | $116.43M | +75.1% |
| 2020 | $66.49M | +47.7% |
| 2019 | $45.02M | +11.1% |
| 2018 | $40.51M | - |